Testing effectiveness (Phase 2)Study completedNCT02138955
What this trial is testing
A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer
Who this might be right for
Patients w/Advanced Cancer That Failed Std of Care Therapy
SignPath Pharma, Inc. 30